CLC bio is the world’s leading bioinformatics solution provider and the only one who provides both desk- top and server software seamlessly integrated and optimized for best performance. By developing their own proprietary algorithms, the scientists at CLC bio have successfully parallelized the data calculations to achieve remarkable improvements in speed over comparable solutions.
High-throughput sequencing is a major focus area for CLC bio which has led to the creation of the first and only comprehensive cross-platform analysis solution that allows the user to analyze, visualize, and com- pare genomic, transcriptomic, and epigenomic data from all major sequencing platforms such as Illumina, Life Technologies, Roche 454, PacBio, and Complete Genomics.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Silkeborgvej 2, Aarhus,middle Jutland 8000,denmark
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- http://clcbio.com
- HQ
- Aarhus, Middle Jutland
Clc Bio (Acquired By Qiagen) Questions
Clc Bio (Acquired By Qiagen)'s website is http://clcbio.com
Clc Bio (Acquired By Qiagen)'s LinkedIn profile is https://dk.linkedin.com/company/clc-bio-acquired-by-qiagen
Clc Bio (Acquired By Qiagen) has
11 employees.
View email and phone details for 11
employees at Clc Bio (Acquired By Qiagen).
Clc Bio (Acquired By Qiagen)'s industry is
Software Development
Clc Bio (Acquired By Qiagen)'s top competitors are
Geneva Bioinformatics,
Rasa Life Science Informatics,
Gatc Biotech Sarl,
Strand Life Sciences,
Sri Technologies,
Ingenuity Systems Inc,
Courtagen Life Sciences Inc,
Ocimum Biosolutions,
Seven Bridges,
Qiagen.
Clc Bio (Acquired By Qiagen)'s categories are Software Development
Clc Bio (Acquired By Qiagen)'s founding year is 2005
